Actual knowledge of systemic inflammation reaction during cardiopulmonary bypass

Recent Patents on Cardiovascular Drug Discovery

Volumn 7, Issue 3, 2012, Pages 165-169

  Belhaj, Asmae ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Cardiopulmonary bypass; Methylprednisolone; Statins; Tnfalpha

Indexed keywords

AMIODARONE; CORTICOSTEROID; FENOLDOPAM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; KETAMINE; MANNITOL; NITROUS OXIDE; PENTOXIFYLLINE; REMIFENTANIL; SEVOFLURANE;

CARDIOPULMONARY BYPASS; DRUG MEGADOSE; HUMAN; INFLAMMATION; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMIC HOST RESPONSE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORAX EPIDURAL ANESTHESIA;

CARDIOPULMONARY BYPASS; HUMANS; POSTOPERATIVE COMPLICATIONS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84870225822     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489012803832784     Document Type: Review

References (45)

1. Messent M, Sullivan K, Keogh BF, Morgan CJ, Evans TW. Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence and prediction. Anaesthesia 1992; 47: 267-8.
2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.
3. Sawa Y, Shimazaki Y, Kadoba K, Masai T, Fukuda H, Ohata T, et al. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg 1996;111: 29-35.
4. Kharazmi A, Andersen LW, Baek L, Valerius NH, Laub M, Rasmussen JP. Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 98: 381-5.
5. Boyle EM, Jr., Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response. Ann Thorac Surg 1997; 63: 277-84.
6. Landow L, Andersen LW. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 1994; 38: 626-39.
7. Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: Lessons learned from cardiac transplantation. Ann Thorac Surg 1997; 63: 269-76.
8. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 1997;85:766-82.
9. Hasegawa A, Iwasaka H, Hagiwara S, Koga H, Hasegawa R, Kudo K, et al. Anti-inflammatory effects of perioperative intensive insulin therapy during cardiac surgery with cardiopulmonary bypass. Surg Today 2011;41:1385-90.
10. Albacker T, Carvalho G, Schricker T, Lachapelle K. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 2008; 86: 20-27.
11. Dieleman JM, van Paassen J, van Dijk D, Arbous MS, Kalkman CJ, Vandenbroucke JP, et al. Prophylactic corticosteroids for cardiopulmonary bypass in adults. Cochrane Database Syst Rev 2011: CD005566.
12. Bocsi J, Hanzka MC, Osmancik P, Hambsch J, Dahnert I, Sack U, et al. Modulation of the cellular and humoral immune response to pediatric open heart surgery by methylprednisolone. Cytometry B Clin Cytom 2011; 80: 212-220.
13. Morgan C, Zappitelli M, Gill P. Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: A systematic review. Crit Care 2009; 13: R165.
14. Martinez-Comendador JM, Alvarez JR, Mosquera I, Sierra J, Adrio B, Carro JG, et al. Preoperative statin treatment reduces systemic inflammatory response and myocardial damage in cardiac surgery. Eur J Cardiothorac Surg 2009;36:998-1005.
15. Zhou Q, Wang G, Gao C, Chen T. [Effect of ulinastatin on perioperative inflammatory response to coronary artery bypass grafting with cardiopulmonary bypass]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010;35:107-110.
16. Dereli Y, Ege E, Kurban S, Narin C, Sarigul A, Yeniterzi M. Pre-operative atorvastatin therapy to decrease the systemic inflammatory response after coronary artery bypass grafting. J Int Med Res 2008;36:1248-1254.
17. Shen Y, Wu H, Wang C, Shao H, Huang H, Jing H, et al. Simvastatin attenuates cardiopulmonary bypass-induced myocardial inflammatory injury in rats by activating peroxisome proliferator-activated receptor gamma. Eur J Pharmacol 2010;649:255-262.
18. Groesdonk HV, Heringlake M, Heinze H. [Anti-inflammatory effects of pentoxifylline: importance in cardiac surgery]. Anaesthesist 2009; 58:1136-1143.
19. Iskesen I, Kurdal AT, Kahraman N, Cerrahoglu M, Sirin BH. Preoperative oral pentoxifylline for management of cytokine reactions in cardiac surgery. Heart Surg Forum 2009;12: E100-104.
20. Elahi MM, Worner M, Khan JS, Matata BM. Inspired nitric oxide and modulation of oxidative stress during cardiac surgery. Curr Drug Saf 2009; 4:188-198.
21. Rahman A, Akbulut H, Bayar MK, Ozden M, Burma O, Uysal A. The effects of intra-operative amiodarone loading on the systemic inflammatory response syndrome induced by cardiopulmonary bypass. Anadolu Kardiyol Derg 2009;9:318-324.
22. Adluri RK, Singh AV, Skoyles J, Robins A, Parton J, Baker M, et al. The effect of fenoldopam and dopexamine on cytokine and endotoxin release following on-pump coronary artery bypass grafting: a prospective randomized double-blind trial. Heart Surg Forum 2010;13: E353-361.
23. Welters ID, Feurer MK, Preiss V, Muller M, Scholz S, Kwapisz M, et al. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth 2011;106:172-179.
24. Cho EJ, Yoon JH, Hong SJ, Lee SH, Sim SB. The effects of sevoflurane on systemic and pulmonary inflammatory responses after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2009;23:639-645.
25. Trillo, R., Lessor, R., Pejaver, S., Puri, N. Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics. US77999011B2 (2011).
26. von Dossow V, Luetz A, Haas A, Sawitzki B, Wernecke KD, Volk HD, et al. Effects of remifentanil and fentanyl on the cell-mediated immune response in patients undergoing elective coronary artery bypass graft surgery. J Int Med Res 2008;36:1235-47.
27. Ziegeler S, Raddatz A, Schneider SO, Sandmann I, Sasse H, Bauer I, et al. Effects of haemofiltration and mannitol treatment on cardiopulmonary-bypass induced immunosuppression. Scand J Immunol 2009;69: 234-241.
28. Assaly, R., Dignam, J., Shapiro, J. Albumin-based colloid composition having at least one protected thiol region, method of making, and method of use. US7884068B2 (2011).
29. Palomero Rodriguez MA, Suarez Gonzalo L, Villar Alvarez F, Varela Crespo C, Moreno Gomez Limon I, Criado Jimenez A. Thoracic epidural anesthesia decreases C-reactive protein levels in patients undergoing elective coronary artery bypass graft surgery with cardiopulmonary bypass. Minerva Anestesiol 2008; 74: 619-26.
30. Jimenez JJ, Iribarren JL, Brouard M, Hernandez D, Palmero S, Jimenez A, et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: A randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg 2011; 6: 138.
31. Vincent, D., Murphy, M. Fluid pump. US7850593B2 (2010).
32. Bayram H, Erer D, Iriz E, Zor MH, Gulbahar O, Ozdogan ME. Comparison of the effects of pulsatile cardiopulmonary bypass, non-pulsatile cardiopulmonary bypass and off-pump coronary artery bypass grafting on the inflammatory response and S-100beta protein. Perfusion 2012;27:56-64.
33. Atkins BZ, Danielson DS, Fitzpatrick CM, Dixon P, Petersen RP, Carpenter AJ. Modified ultrafiltration attenuates pulmonary-derived inflammatory mediators in response to cardiopulmonary bypass. Interact Cardiovasc Thorac Surg 2010;11:599-603.
34. Ugaki S, Honjo O, Kotani Y, Nakakura M, Douguchi T, Oshima Y, et al. Ultrafiltration of priming blood before cardiopulmonary bypass attenuates inflammatory response and maintains cardiopulmonary function in neonatal piglets. Asaio J 2009; 55: 291-5.
35. Onorati F, Santini F, Mariscalco G, Bertolini P, Sala A, Faggian G, et al. Leukocyte filtration ameliorates the inflammatory response in patients with mild to moderate lung dysfunction. Ann Thorac Surg 2011; 92:111-21.
36. Vohra HA, Whistance R, Modi A, Ohri SK. The inflammatory response to miniaturised extracorporeal circulation: A review of the literature. Mediators Inflamm 2009; 707042.
37. Rimmele T, Venkataraman R, Madden NJ, Elder MM, Wei LM, Pellegrini RV, et al. Comparison of inflammatory response during on-pump and off-pump coronary artery bypass surgery. Int J Artif Organs 2010; 33:131-138.
38. Onorati F, Rubino AS, Nucera S, Foti D, Sica V, Santini F, et al. Off-pump coronary artery bypass surgery versus standard linear or pulsatile cardiopulmonary bypass: Endothelial activation and inflammatory response. Eur J Cardiothorac Surg 2010;37:897-904.
39. Sohn N, Marcoux J, Mycyk T, Krahn J, Meng Q. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Perfusion 2009; 24: 231-7.
40. Moen O, Hogasen K, Fosse E, Dregelid E, Brockmeier V, Venge P, et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997;63:105-111.
41. Ericson, D., Thor, E., Haworth, W. Hemostatic system and components for extracorporeal circuit. US7153473B2 (2006).
42. Fritz, O., Fritz, U., Denk, R., Wilson, T., Gaskins, R. Vasodilator eluting medical devices with a specific polyphosphazene coating and methods for their manufacture and use. US20080138792A1 (2008).
43. Damgaard S, Nielsen CH, Andersen LW, Bendtzen K, Tvede M, Steinbruchel DA. Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial. Ann Thorac Surg 2010; 89:1511-7.
44. Stocker CF, Shekerdemian LS, Horton SB, Lee KJ, Eyres R, D'Udekem Y, et al. The influence of bypass temperature on the systemic inflammatory response and organ injury after pediatric open surgery: a randomized trial. J Thorac Cardiovasc Surg 2011;142:174-80.
45. Khaladj N, Peterss S, Pichlmaier M, Shrestha M, von Wasielewski R, Hoy L, et al. The impact of deep and moderate body temperatures on end-organ function during hypothermic circulatory arrest. Eur J Cardiothorac Surg 2011; 40:1492-9.